angiotensin ii has been researched along with Carotid Artery Diseases in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.33) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 10 (33.33) | 29.6817 |
| 2010's | 11 (36.67) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, W; Han, J; Liu, J; Wang, Z; Wen, S; Zhou, Q | 1 |
| Clancy, P; Golledge, J; Koblar, SA; Seto, SW | 1 |
| Chen, J; Ding, J; Guo, Q; Hu, Q; Jiang, H; Xu, C; Yang, J; Zhang, J | 1 |
| Clancy, P; Golledge, J; Koblar, S | 1 |
| Bricca, G; Kobeissy, F; Marcelo, P; Nasser, R; Nehme, A; Zibara, K | 1 |
| Jin, F; Sun, X; Wang, K; Zhang, Z | 1 |
| Algür, M; Cheng, C; de Crom, R; Krams, R; Tempel, D; van Damme, L; van Haperen, R | 1 |
| Ahluwalia, A; Duchene, J; Hodgkinson, CP; Hu, Y; Kiechl, S; Laxton, RC; Leung, KY; López-Otín, C; Scotland, RS; Simpson, IA; Smith, K; Willeit, J; Xiao, Q; Xu, Q; Ye, S; Zhang, F; Zhang, Z | 1 |
| Ali, ZA; Anderson, JA; Ashley, EA; Chun, HJ; Cox, CM; Kojima, Y; Krieg, PA; Kundu, RK; Leeper, NJ; Quertermous, T | 1 |
| Blinder, Y; Chen, W; Funt, SA; Harrison, DG; Iwakura, Y; Li, L; Lob, HE; Madhur, MS; Quyyumi, AA; Rahman, A; Vinh, A | 1 |
| Aono, J; Higaki, J; Horiuchi, M; Inoue, K; Iwai, M; Nagai, T; Nishimura, K; Ogimoto, A; Okayama, H; Suzuki, J | 1 |
| Agrawal, DK; Gangahar, DM; Jia, G; Stormont, RM | 1 |
| Chen, XJ; He, B; Hu, LH; Jin, SX; Li, DD; Nie, P; Shen, LH; Yuan, W; Zhang, XK | 1 |
| Garzon-Muvdi, T; Jackson, C; Pradilla, G; Ruzevick, J; Tamargo, RJ | 1 |
| Campos, AH; Gibbons, GH; Pollman, MJ; Wang, W | 1 |
| Whitman, SC | 1 |
| Böckler, D; Braun-Dullaeus, R; Daniel, WG; Garlichs, CD; Graffy, C; Illmer, T; Marquetant, R; Menschikowski, D; Schmeisser, A; Strasser, RH | 1 |
| Jin, D; Kirimura, K; Mino, Y; Miyazaki, M; Muramatsu, M; Takai, S; Yoshikawa, K | 1 |
| Choy, DF; da Cunha, V; Halks-Miller, M; Li, WW; Mahmoudi, M; Martin-McNulty, B; Schroeder, M; Sullivan, ME; Vergona, R; Vincelette, J; Wang, YX; Wilson, DW | 1 |
| da Cunha, V; Martin-McNulty, B; Rutledge, JC; Sullivan, ME; Vergona, R; Vincelette, J; Wang, YX; Zhang, L | 1 |
| Berndt, MC; Fahmy, RG; Kavurma, MM; Khachigian, LM; Luo, X; Midgley, VC; Molloy, MP; Peden, R; Santiago, FS; Tan, NY | 1 |
| Brosnihan, KB; Ferrario, CM; Masaki, Z; Szilagyi, JE | 1 |
| Pavan, E; Pessina, AC; Rossi, A; Rossi, G; Sacchetto, A | 1 |
| Imura, Y; Kawamura, M; Nakao, M; Nishikawa, K; Okuda, H; Shino, A; Terashita, Z | 1 |
| Daemen, MJ; Fingerle, J; van Kleef, EM | 1 |
| Dean, RH; Diz, DI; Ferrario, CM; Fukuhara, M; Gallagher, PE; Geary, RL; Glazier, SS; Wilson, JA | 1 |
| Ehmke, H; Kirchheim, HR; Nafz, B; Persson, PB | 1 |
| Dabney, JM; Dobbins, DE; Soika, CY | 1 |
| Baumann, R; Michailov, ML; Nitschkoff, S; Pohl, J | 1 |
| McCloy, RB; Nakano, J | 1 |
1 review(s) available for angiotensin ii and Carotid Artery Diseases
| Article | Year |
|---|---|
Hypertensive cerebrovascular disease and the renin-angiotensin system.
Topics: Angiotensin II; Animals; Arteriosclerosis; Carotid Artery Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Humans; Hypertension; Intracranial Embolism and Thrombosis; Renin-Angiotensin System | 1995 |
29 other study(ies) available for angiotensin ii and Carotid Artery Diseases
| Article | Year |
|---|---|
C1q/TNF-related protein-9 is elevated in hypertension and associated with the occurrence of hypertension-related atherogenesis.
Topics: Adipokines; Adiponectin; Adult; Aged; Angiotensin II; Animals; Atherosclerosis; Carotid Artery Diseases; Complement C1q; Endothelial Cells; Female; Glycoproteins; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Middle Aged | 2021 |
Role of the angiotensin converting enzyme 1/angiotensin II/angiotensin receptor 1 axis in interstitial collagenase expression in human carotid atheroma.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Carotid Artery Diseases; Collagenases; Dipeptides; Elastin; Endarterectomy, Carotid; Extracellular Matrix; Humans; Irbesartan; Matrix Metalloproteinase 1; Matrix Metalloproteinase 13; Matrix Metalloproteinase 8; Matrix Metalloproteinase Inhibitors; Organ Culture Techniques; Peptides; Peptidyl-Dipeptidase A; Plaque, Atherosclerotic; Quinapril; Receptor, Angiotensin, Type 1; Signal Transduction; Tetrahydroisoquinolines; Tetrazoles | 2013 |
Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model.
Topics: Angioplasty, Balloon; Angiotensin II; Animals; Carotid Arteries; Carotid Artery Diseases; Cell Movement; Cell Proliferation; Cells, Cultured; Coumaric Acids; Drug Evaluation, Preclinical; Hyperplasia; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2014 |
Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase Regulation in Human Carotid Atheroma in vitro.
Topics: Aged; Angiotensin II; Blotting, Western; Carotid Artery Diseases; Enzyme-Linked Immunosorbent Assay; Gelatinases; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Male; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2016 |
The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1-7).
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Carotid Artery Diseases; Chromatography, High Pressure Liquid; Disease Progression; Humans; Mass Spectrometry; Peptide Fragments; Plaque, Atherosclerotic; Time Factors | 2016 |
Angiotensin II Promotes the Development of Carotid Atherosclerosis in Type 2 Diabetes Patients via Regulating the T Cells Activities: A Cohort Study.
Topics: Adult; Aged; Angiotensin II; Carotid Artery Diseases; Cohort Studies; Cytokines; Diabetes Mellitus, Type 2; Female; Humans; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Middle Aged; Phenotype; T-Lymphocyte Subsets; T-Lymphocytes | 2016 |
Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype.
Topics: Angiotensin II; Animals; Apolipoproteins E; Blood Pressure; Carotid Artery Diseases; Carotid Artery, Common; Collagen Type I; Disease Models, Animal; Enzyme Activation; Fibrosis; Gene Expression Profiling; Hemorrhage; Infusion Pumps, Implantable; Infusions, Subcutaneous; Macrophages; Matrix Metalloproteinase 13; Matrix Metalloproteinase 8; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Procollagen; Severity of Illness Index; Tissue Inhibitor of Metalloproteinases | 2009 |
A role of matrix metalloproteinase-8 in atherosclerosis.
Topics: Angiotensin II; Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Carotid Artery Diseases; Collagen; Coronary Stenosis; Disease Models, Animal; Disease Progression; Endothelium, Vascular; Gene Frequency; Genetic Predisposition to Disease; Humans; Leukocyte Rolling; Macrophages; Male; Matrix Metalloproteinase 8; Mice; Mice, Knockout; Polymorphism, Single Nucleotide; Prospective Studies; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2009 |
Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse.
Topics: Adipokines; Angiotensin II; Animals; Aortic Diseases; Apelin; Apelin Receptors; Apolipoproteins E; Carotid Artery Diseases; Carotid Artery, Common; Carrier Proteins; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Intercellular Signaling Peptides and Proteins; Ligation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Paracrine Communication; Rats; Receptors, G-Protein-Coupled; RNA, Messenger; Time Factors; Tunica Intima; Up-Regulation | 2010 |
Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.
Topics: Aged; Angiotensin II; Animals; Antibodies, Neutralizing; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Cells, Cultured; Dendritic Cells; Dietary Fats; Disease Models, Animal; Female; Humans; Inflammation; Interferon-gamma; Interleukin-17; Ligation; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nitric Oxide; Spleen; Superoxides; Time Factors | 2011 |
Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apolipoproteins E; Atherosclerosis; Carotid Artery Diseases; Carotid Artery, Common; CD36 Antigens; Disease Models, Animal; Disease Progression; Focal Adhesion Kinase 1; Gene Deletion; JNK Mitogen-Activated Protein Kinases; Lipids; Lipoproteins, LDL; Macrophages; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Plaque, Atherosclerotic; Receptor, Angiotensin, Type 1; Rupture, Spontaneous; Superoxides; Tetrazoles; Time Factors; Valine; Valsartan | 2012 |
Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification.
Topics: Aged; Angiotensin II; Apoptosis; Blotting, Western; Calcium Phosphates; Calcium-Binding Proteins; Carotid Arteries; Carotid Artery Diseases; Caspase 3; Cells, Cultured; Core Binding Factor Alpha 1 Subunit; Cytokines; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Feedback, Physiological; Gene Expression Regulation; Humans; In Situ Nick-End Labeling; Inflammation Mediators; Matrix Gla Protein; Middle Aged; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Plaque, Atherosclerotic; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 1; Signal Transduction; Time Factors; Transfection; Vascular Calcification | 2012 |
Endogenous renovascular hypertension combined with low shear stress induces plaque rupture in apolipoprotein E-deficient mice.
Topics: Angiotensin II; Animals; Apolipoproteins E; Blood Pressure; Carotid Artery Diseases; Carotid Artery, Common; Collagen; Collagenases; Disease Models, Animal; Female; Hemorrhage; Hypertension, Renovascular; Incidence; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Plaque, Atherosclerotic; Stress, Mechanical | 2012 |
Aneurysm formation in proinflammatory, transgenic haptoglobin 2-2 mice.
Topics: Angiotensin II; Animals; Blood Pressure; Carotid Arteries; Carotid Artery Diseases; Genotype; Haptoglobins; Hypertension; Immunohistochemistry; Intracranial Aneurysm; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neutrophil Infiltration; Pancreatic Elastase | 2013 |
Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation.
Topics: Angiotensin II; Animals; Basic Helix-Loop-Helix Transcription Factors; Calcium-Binding Proteins; Carotid Arteries; Carotid Artery Diseases; Cell Cycle; Cell Cycle Proteins; Cell Division; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; DNA-Binding Proteins; Down-Regulation; Drosophila Proteins; Glycosylation; Immunoglobulin J Recombination Signal Sequence-Binding Protein; Insect Proteins; Intercellular Signaling Peptides and Proteins; Jagged-1 Protein; Male; Membrane Proteins; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Nuclear Proteins; Platelet-Derived Growth Factor; Proteins; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Notch1; Receptor, Notch2; Receptors, Cell Surface; RNA, Messenger; Serrate-Jagged Proteins; Signal Transduction; Transcription Factors; Tumor Suppressor Proteins | 2002 |
All of the components required for angiotensin II formation are expressed locally in human atherosclerotic lesions, including a long suspected player cathepsin G.
Topics: Angiotensin II; Angiotensinogen; Carotid Artery Diseases; Carotid Artery, Common; Cathepsin D; Cathepsin G; Cathepsins; Humans; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; RNA, Messenger; Serine Endopeptidases | 2004 |
The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability.
Topics: Aged; Angiotensin II; Arteritis; Carotid Artery Diseases; Case-Control Studies; CD40 Ligand; Cell Hypoxia; Cells, Cultured; Endothelial Cells; Female; Glucose; Humans; Insulin; Intracranial Arteriosclerosis; Macrophage Migration-Inhibitory Factors; Male; Microcirculation; Middle Aged; Monocytes; Protein Isoforms; Recombinant Fusion Proteins | 2005 |
Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Carotid Artery Diseases; Gene Expression; Hypertension; Immunohistochemistry; Lipids; Losartan; Male; Membrane Transport Proteins; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type III; Organ Size; Phosphoproteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin; Telmisartan; Vasodilation | 2005 |
Angiotensin II induces histomorphologic features of unstable plaque in a murine model of accelerated atherosclerosis.
Topics: Angiotensin II; Animals; Apolipoproteins E; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Chemokine CCL2; Disease Models, Animal; Foam Cells; Immunohistochemistry; Ligation; Male; Matrix Metalloproteinase 2; Mice; Mice, Knockout; Tunica Intima; Vascular Cell Adhesion Molecule-1 | 2006 |
Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice.
Topics: Angiotensin II; Animals; Carotid Artery Diseases; Infusion Pumps, Implantable; Ligation; Mice; Mice, Inbred C57BL; Mice, Knockout; Urokinase-Type Plasminogen Activator; Vasoconstrictor Agents | 2007 |
Angiotensin II-inducible platelet-derived growth factor-D transcription requires specific Ser/Thr residues in the second zinc finger region of Sp1.
Topics: Angiotensin II; Animals; Antibodies; Carotid Artery Diseases; Catheterization; Cells, Cultured; Disease Models, Animal; Humans; Lymphokines; Muscle, Smooth, Vascular; Mutagenesis; Phosphorylation; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Protein Kinase C; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Serine; Sp1 Transcription Factor; Spectrometry, Mass, Electrospray Ionization; Threonine; Transcription, Genetic; Vasoconstrictor Agents; Zinc Fingers | 2008 |
Neurogenic suppression of carotid sinus reflexes by vagal afferents in sodium-depleted dogs.
Topics: Afferent Pathways; Angiotensin II; Animals; Atropine; Autonomic Nervous System; Cardiovascular System; Carotid Artery Diseases; Carotid Sinus; Constriction, Pathologic; Dogs; Male; Reflex, Abnormal; Sodium; Vagus Nerve | 1981 |
TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.
Topics: Acetylcholine; Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Carotid Arteries; Carotid Artery Diseases; Catheterization; Cell Division; Disease Models, Animal; DNA; Endothelium, Vascular; Male; Microscopy, Electron, Scanning; Muscle Relaxation; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Tetrazoles; Tunica Intima | 1993 |
Angiotensin II-induced progression of neointimal thickening in the balloon-injured rat carotid artery is AT1 receptor mediated.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Carotid Arteries; Carotid Artery Diseases; Catheterization; DNA; Imidazoles; Losartan; Male; Pyridines; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 1996 |
Angiotensin-converting enzyme expression in human carotid artery atherosclerosis.
Topics: Aged; Angiotensin II; Carotid Arteries; Carotid Artery Diseases; Endarterectomy, Carotid; Female; Gene Expression Regulation, Enzymologic; Humans; In Situ Hybridization; Macrophages; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; RNA, Messenger | 2000 |
Resetting of renal autoregulation in conscious dogs: angiotensin II and alpha1-adrenoceptors.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Carotid Artery Diseases; Consciousness; Dogs; Female; Glomerular Filtration Rate; Hemodynamics; Hemostasis; Kidney; Male; Methoxamine; Receptors, Adrenergic, alpha; Regional Blood Flow; Renin-Angiotensin System; Saralasin | 1990 |
Evidence for constriction of canine prenodal lymphatic vessels by vasoactive agents and carotid occlusion.
Topics: Angiotensin II; Animals; Arterial Occlusive Diseases; Blood Pressure; Bombesin; Bradykinin; Cardiotonic Agents; Carotid Artery Diseases; Dogs; Infusions, Intra-Arterial; Leg; Lymph; Lymphatic System; Norepinephrine; Serotonin; Vasoconstriction | 1985 |
[Studies of the free fatty acid pattern in blood plasma in experimental neurogenic-interoceptive hypertension and during administration of angiotension II in the rabbit].
Topics: Angiotensin II; Animals; Blood Pressure; Carotid Artery Diseases; Carotid Sinus; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Hypertension; Lipid Metabolism; Male; Oleic Acids; Palmitic Acids; Pressoreceptors; Rabbits | 1973 |
Effects of prostaglandin E1 and 15-methyl- prostaglandin E1 on the cardiovascular responses to bilateral carotid arterial occlusion.
Topics: Angiotensin II; Animals; Arterial Occlusive Diseases; Blood Pressure; Carotid Arteries; Carotid Artery Diseases; Catheterization; Depression, Chemical; Dogs; Heart Rate; Heart Ventricles; Hemodynamics; Infusions, Parenteral; Ligation; Lysine; Nitroglycerin; Prostaglandins; Prostaglandins E; Stimulation, Chemical; Transducers; Vagotomy; Vasopressins | 1974 |